Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147590 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Deborah Utjés und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden. Hauptthemen laut MEDLINE: Receptors, Progesterone, Mifepristone, Premenopause, Transcriptome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish research council, Swedish Cancer foundation, the joint grant from Stockholm County Council and Karolinska Institutet (ALF.
Abstract (Originalsprache)
Progesterone receptor antagonism is gaining attention due to progesterone’s recognized role as a major mitogen in breast tissue. Limited but promising data suggest the potential efficacy of antiprogestins in breast cancer prevention. The present study presents secondary outcomes from a randomized controlled trial and examines changes in breast mRNA expression following mifepristone treatment in healthy premenopausal women. We analyzed 32 paired breast biopsies from 16 women at baseline and after two months of mifepristone treatment. In total, 27 differentially expressed genes were identified, with enriched biological functions related to extracellular matrix remodeling. Notably, the altered gene signature induced by mifepristone in vivo was rather similar to the in vitro signature. Furthermore, this gene expression signature was linked to breast carcinogenesis and notably linked with progesterone receptor expression status in breast cancer, as validated in The Cancer Genome Atlas dataset using the R2 platform. The present study is the first to explore the breast transcriptome following mifepristone treatment in normal breast tissue in vivo, enhancing the understanding of progesterone receptor antagonism and its potential protective effect against breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.
- Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, 141 57 Stockholm, Sweden.
- Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Tishk International University, Erbil 44001, Iraq.
- General Directorate of Scientific Research Center, Salahaddin University-Erbil, Erbil 44001, Iraq.
- WHO Collaborating Centre, Division of Gynecology and Reproduction, Karolinska University Hospital, 171 76 Stockholm, Sweden.
ORCID-Profile: Deborah Utjés, Nageswara Rao Boggavarapu, Isabelle Koberg, Alexander Zulliger, Sakthivignesh Ponandai-Srinivasan, Carolina von Grothusen, Parameswaran Grace Lalitkumar, Kiriaki Papaikonomou, Twana Alkasalias, Kristina Gemzell-Danielsson
Förderung
- Swedish research council
- Swedish Cancer foundation
- the joint grant from Stockholm County Council and Karolinska Institutet (ALF
- Stockholm County Council and Karolinska Institutet (ALF)
Zitieren
APA
Utjés, D., Boggavarapu, N. R., Rasul, M. F., Koberg, I., Zulliger, A., Ponandai-Srinivasan, S., von Grothusen, C., Lalitkumar, P. G., Papaikonomou, K., Alkasalias, T., & Gemzell-Danielsson, K. (2024). Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147590
Vancouver
Utjés D, Boggavarapu NR, Rasul MF, Koberg I, Zulliger A, Ponandai-Srinivasan S, et al. Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147590
BibTeX
@article{Utjs2024,
author = {Utjés, Deborah and Boggavarapu, Nageswara Rao and Rasul, Mohammed Fatih and Koberg, Isabelle and Zulliger, Alexander and Ponandai-Srinivasan, Sakthivignesh and von Grothusen, Carolina and Lalitkumar, Parameswaran Grace and Papaikonomou, Kiriaki and Alkasalias, Twana and Gemzell-Danielsson, Kristina},
title = {Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147590}
}
EUVIMED